Skip to Content
Artificial intelligence

DeepMind’s AI will accelerate drug discovery by predicting how proteins fold

December 3, 2018

Google DeepMind has developed a tool to predict the structure of proteins from their genetic sequence, marking a noteworthy example of using AI in the process of scientific discovery.

How it works: The system, called AlphaFold, models the complex folding patterns of long chains of amino acids, based on their chemical interactions, to form the three-dimensional shape of a protein. This is known as the “protein folding problem,” which has challenged scientists for decades.

Why it matters: The shape of a protein dictates its function in the body, so being able to predict a protein’s structure allows scientists to synthesize new protein-based drugs to treat diseases or new enzymes to break down pollutants in our environment.

Training data: The DeepMind team trained deep neural networks to predict the distances between pairs of amino acids and the angles between their chemical bonds, using the massive amounts of data available from genomic sequencing. The resulting system generates highly accurate protein structures, exceeding previous prediction techniques, the team says.

The bigger picture: DeepMind isn’t the only one working to accelerate scientific discovery with machine learning. Many other companies and researchers have sought to develop algorithms for discovering new drugs and new materials. 

Deep Dive

Artificial intelligence

Sam Altman says helpful agents are poised to become AI’s killer function

Open AI’s CEO says we won’t need new hardware or lots more training data to get there.

Is robotics about to have its own ChatGPT moment?

Researchers are using generative AI and other techniques to teach robots new skills—including tasks they could perform in homes.

What’s next for generative video

OpenAI's Sora has raised the bar for AI moviemaking. Here are four things to bear in mind as we wrap our heads around what's coming.

An AI startup made a hyperrealistic deepfake of me that’s so good it’s scary

Synthesia's new technology is impressive but raises big questions about a world where we increasingly can’t tell what’s real.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.